Go Pro
→ They didn't warn anyone in 1971. This time someone is warning you. (From Reagan Gold Group) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
$0.77
+9.2%		$0.69
$0.36
▼
$1.89
$54.20M1.9329,211 shs259,247 shs
electroCore, Inc. stock logo
ECOR
electroCore
$9.12
+1.8%		$7.66
$4.25
▼
$10.49
$80.78M0.9377,382 shs76,563 shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$0.89
+5.7%		$1.04
$0.80
▼
$1.65
$14.65M0.6655,740 shs74,086 shs
Nyxoah SA stock logo
NYXH
Nyxoah
$1.59
+0.6%		$1.60
$1.26
▼
$7.22
$61.24M1.62137,793 shs91,311 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
+9.22%+11.90%+12.69%+17.06%-50.48%
electroCore, Inc. stock logo
ECOR
electroCore
+1.79%+46.39%+38.39%+44.30%+111.60%
IRIDEX Corporation stock logo
IRIX
IRIDEX
+5.69%+8.49%-19.11%-13.61%-29.38%
Nyxoah SA stock logo
NYXH
Nyxoah
+0.63%+9.66%-7.02%-48.38%-77.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
$0.77
+9.2%		$0.69
$0.36
▼
$1.89
$54.20M1.9329,211 shs259,247 shs
electroCore, Inc. stock logo
ECOR
electroCore
$9.12
+1.8%		$7.66
$4.25
▼
$10.49
$80.78M0.9377,382 shs76,563 shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$0.89
+5.7%		$1.04
$0.80
▼
$1.65
$14.65M0.6655,740 shs74,086 shs
Nyxoah SA stock logo
NYXH
Nyxoah
$1.59
+0.6%		$1.60
$1.26
▼
$7.22
$61.24M1.62137,793 shs91,311 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
+9.22%+11.90%+12.69%+17.06%-50.48%
electroCore, Inc. stock logo
ECOR
electroCore
+1.79%+46.39%+38.39%+44.30%+111.60%
IRIDEX Corporation stock logo
IRIX
IRIDEX
+5.69%+8.49%-19.11%-13.61%-29.38%
Nyxoah SA stock logo
NYXH
Nyxoah
+0.63%+9.66%-7.02%-48.38%-77.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
2.00
Hold$2.25192.21% Upside
electroCore, Inc. stock logo
ECOR
electroCore
2.00
Hold$18.0097.37% Upside
IRIDEX Corporation stock logo
IRIX
IRIDEX
2.00
Hold$3.00237.15% Upside
Nyxoah SA stock logo
NYXH
Nyxoah
2.25
Hold$5.26230.94% Upside

Current Analyst Ratings Breakdown

Latest IRIX, ECOR, NYXH, and COCH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/6/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/6/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$2.31
8/6/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$7.00 ➝ $6.00
8/6/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$4.00
7/27/2026
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
Loop Capital logo
Loop Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$2.00
7/21/2026
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/15/2026
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$2.50
7/9/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$2.85
7/1/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
6/24/2026
electroCore, Inc. stock logo
ECOR
electroCore
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 8/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
$207K285.98N/AN/A($0.42) per share-1.83
electroCore, Inc. stock logo
ECOR
electroCore
$36.97M2.22N/AN/A($0.31) per share-29.42
IRIDEX Corporation stock logo
IRIX
IRIDEX
$52.67M0.29N/AN/A($0.06) per share-14.83
Nyxoah SA stock logo
NYXH
Nyxoah
$11.33M5.44N/AN/A$2.49 per share0.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
-$23.76M-$0.76N/AN/AN/A-11,304.83%N/A-163.70%N/A
electroCore, Inc. stock logo
ECOR
electroCore
-$13.97M-$1.66N/AN/AN/A-39.96%-1,956.38%-81.35%N/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$4.44M-$0.19N/AN/AN/A-6.23%N/A-11.16%8/18/2026 (Estimated)
Nyxoah SA stock logo
NYXH
Nyxoah
-$101.92M-$2.52N/AN/AN/A-443.16%-178.90%-81.83%N/A

Latest IRIX, ECOR, NYXH, and COCH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/18/2026Q2 2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$0.01N/AN/AN/A$13.59 millionN/A
8/10/2026Q2 2026
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
-$0.08-$0.07+$0.01-$0.07$0.05 million$0.05 million
8/6/2026Q2 2026
electroCore, Inc. stock logo
ECOR
electroCore
-$0.4218-$0.33+$0.0918-$0.33$9.49 million$9.45 million
8/5/2026Q2 2026
Nyxoah SA stock logo
NYXH
Nyxoah
-$0.47-$0.67-$0.20-$0.66$8.64 million$8.76 million
5/19/2026Q1 2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$0.07-$0.03+$0.04-$0.03$11.91 million$11.80 million
5/12/2026Q1 2026
Nyxoah SA stock logo
NYXH
Nyxoah
-$0.54-$0.43+$0.11-$0.43$7.05 million$7.38 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
N/AN/AN/AN/AN/A
electroCore, Inc. stock logo
ECOR
electroCore
N/AN/AN/AN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/AN/AN/AN/AN/A
Nyxoah SA stock logo
NYXH
Nyxoah
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
N/A
2.27
2.14
electroCore, Inc. stock logo
ECOR
electroCore
N/A
1.21
1.00
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/A
1.92
1.19
Nyxoah SA stock logo
NYXH
Nyxoah
0.44
2.38
2.31

Institutional Ownership

CompanyInstitutional Ownership
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
8.59%
electroCore, Inc. stock logo
ECOR
electroCore
26.74%
IRIDEX Corporation stock logo
IRIX
IRIDEX
20.10%
Nyxoah SA stock logo
NYXH
Nyxoah
N/A

Insider Ownership

CompanyInsider Ownership
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
7.10%
electroCore, Inc. stock logo
ECOR
electroCore
7.80%
IRIDEX Corporation stock logo
IRIX
IRIDEX
8.60%
Nyxoah SA stock logo
NYXH
Nyxoah
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
3476.88 million71.42 millionNot Optionable
electroCore, Inc. stock logo
ECOR
electroCore
509.02 million8.31 millionNot Optionable
IRIDEX Corporation stock logo
IRIX
IRIDEX
12017.41 million15.91 millionOptionable
Nyxoah SA stock logo
NYXH
Nyxoah
11038.76 millionN/ANot Optionable

Recent News About These Companies

Nyxoah (NASDAQ:NYXH) Downgraded to Sell Rating by Wall Street Zen
August 9 at 1:06 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30949123
Wall Street Zen Downgrades Nyxoah (NASDAQ:NYXH) to Sell
August 9 at 1:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/wall-street-zen-downgrades-nyxoah-nasdaqnyxh-to-sell-2026-08-09/
Nyxoah (NASDAQ:NYXH) Releases Earnings Results, Misses Expectations By $0.20 EPS
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nyxoah-nasdaqnyxh-releases-earnings-results-misses-expectations-by-020-eps-2026-08-06/
Nyxoah SA (NYXH) Q2 2026 Earnings Call Transcript
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931411-nyxoah-sa-nyxh-q2-2026-earnings-call-transcript
Nyxoah Q2 Earnings Call Highlights
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nyxoah-q2-earnings-call-highlights-2026-08-05/
Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339674/0/en/nyxoah-reports-second-quarter-and-first-half-2026-financial-and-operating-results.html
Health Catalyst (NASDAQ:HCAT) vs. Nyxoah (NASDAQ:NYXH) Head-To-Head Survey
August 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30935596
Nyxoah (NASDAQ:NYXH) Upgraded by Wall Street Zen to "Hold" Rating
August 1, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30933691
Nyxoah (NASDAQ:NYXH) Stock Rating Upgraded by Wall Street Zen
August 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nyxoah-nasdaqnyxh-stock-rating-upgraded-by-wall-street-zen-2026-08-01/
Nyxoah (NYXH) Projected to Release Earnings on Wednesday
July 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nyxoah-nyxh-projected-to-release-earnings-on-wednesday-2026-07-29/
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333855/0/en/nyxoah-to-release-second-quarter-2026-financial-results-on-august-5-2026.html
Short Interest in Nyxoah SA (NASDAQ:NYXH) Drops By 63.9%
July 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/short-interest-in-nyxoah-sa-nasdaqnyxh-drops-by-639-2026-07-13/
Nyxoah touts Genio US launch traction, reimbursement stability at investor day
July 11, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/nyxoah-touts-genio-us-launch-traction-reimbursement-stability-at-investor-day/ar-AA27FKRx
Nyxoah SA (NYXH) Analyst/Investor Day Transcript
July 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4920699-nyxoah-sa-nyxh-analyst-investor-day-transcript
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst Caution
July 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/nyxoah-enxtbr-nyxh-stock-fair-091502439.html
Nyxoah reports Q2 2026 preliminary revenue of €7.7M
July 7, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/nyxoah-reports-q2-2026-preliminary-revenue-of-77m/ar-AA27q7EB
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
July 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/07/3323627/0/en/nyxoah-announces-preliminary-results-for-the-second-quarter-of-2026.html
Information on the total number of voting rights and shares
June 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/30/3320146/0/en/information-on-the-total-number-of-voting-rights-and-shares.html
Publication relating to transparency notifications
June 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/29/3319310/0/en/publication-relating-to-transparency-notifications.html
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns
June 24, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/nyxoah-enxtbr-nyxh-stock-fair-043059720.html
Nyxoah to Host Investor Day in New York on July 8, 2026
June 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/23/3316416/0/en/nyxoah-to-host-investor-day-in-new-york-on-july-8-2026.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A Patriot missile launcher and soldier on an airbase tarmac as an F-35 fighter jet flies overhead at sunset.
RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
By Dan Schmidt | July 26, 2026
First Internet Bancorp logo illuminated on a glass panel beside a bank card and smartphone with financial charts.
System Upgrade: First Internet Bancorp Options Surge
By Jeffrey Neal Johnson | August 4, 2026
Illustration of the Google "G" logo surrounded by colorful light streaks and digital data effects.
Alphabet Crushed Earnings, But One Number Spooked the Market
By Ryan Hasson | July 23, 2026
Illustration of the Apple logo glowing on a circuit board encased in a translucent box against a digital backdrop.
Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
By Sam Quirke | July 15, 2026
Tesla vehicle parked infront of a sleek depiction of a company building.
Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off?
By Sam Quirke | July 24, 2026
Envoy Medical stock logo

Envoy Medical NASDAQ:COCH

$0.77 +0.07 (+9.22%)
Closing price 08/11/2026 04:00 PM Eastern
Extended Trading
$0.76 -0.01 (-0.78%)
As of 08/11/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

electroCore stock logo

electroCore NASDAQ:ECOR

$9.12 +0.16 (+1.79%)
Closing price 08/11/2026 04:00 PM Eastern
Extended Trading
$9.02 -0.09 (-1.04%)
As of 08/11/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

IRIDEX stock logo

IRIDEX NASDAQ:IRIX

$0.89 +0.05 (+5.69%)
Closing price 08/11/2026 04:00 PM Eastern
Extended Trading
$0.90 +0.01 (+0.58%)
As of 08/11/2026 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Nyxoah stock logo

Nyxoah NASDAQ:NYXH

$1.59 +0.01 (+0.63%)
Closing price 08/11/2026 04:00 PM Eastern
Extended Trading
$1.60 +0.01 (+0.63%)
As of 08/11/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas